Quadrant Capital Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$236K Buy
7,492
+705
+10% +$22.2K 0.01% 1239
2025
Q1
$222K Buy
6,787
+5,316
+361% +$174K 0.01% 1241
2024
Q4
$53.2K Hold
1,471
﹤0.01% 1379
2024
Q3
$45.9K Hold
1,471
﹤0.01% 1494
2024
Q2
$39.4K Sell
1,471
-817
-36% -$21.9K ﹤0.01% 1527
2024
Q1
$78K Buy
2,288
+839
+58% +$28.6K 0.01% 1140
2023
Q4
$41.9K Buy
1,449
+1,330
+1,118% +$38.5K ﹤0.01% 1487
2023
Q3
$3.28K Sell
119
-188
-61% -$5.18K ﹤0.01% 2275
2023
Q2
$9.23K Buy
307
+38
+14% +$1.14K ﹤0.01% 2026
2023
Q1
$9.75K Buy
269
+100
+59% +$3.62K ﹤0.01% 2034
2022
Q4
$6.03K Sell
169
-373
-69% -$13.3K ﹤0.01% 2160
2022
Q3
$18K Buy
542
+400
+282% +$13.3K ﹤0.01% 1618
2022
Q2
$4K Buy
142
+13
+10% +$366 ﹤0.01% 2056
2022
Q1
$4K Hold
129
﹤0.01% 1996
2021
Q4
$4K Sell
129
-21
-14% -$651 ﹤0.01% 1973
2021
Q3
$4K Buy
150
+14
+10% +$373 ﹤0.01% 1966
2021
Q2
$4K Buy
136
+7
+5% +$206 ﹤0.01% 1944
2021
Q1
$3K Hold
129
﹤0.01% 1990
2020
Q4
$3K Buy
129
+21
+19% +$488 ﹤0.01% 1870
2020
Q3
$2K Hold
108
﹤0.01% 1862
2020
Q2
$3K Hold
108
﹤0.01% 1841
2020
Q1
$2K Buy
108
+47
+77% +$870 ﹤0.01% 1902
2019
Q4
$1K Hold
61
﹤0.01% 2354
2019
Q3
$1K Sell
61
-797
-93% -$13.1K ﹤0.01% 2224
2019
Q2
$28K Buy
858
+797
+1,307% +$26K ﹤0.01% 1498
2019
Q1
$2K Hold
61
﹤0.01% 2092
2018
Q4
$2K Hold
61
﹤0.01% 1944
2018
Q3
$3K Sell
61
-38
-38% -$1.87K ﹤0.01% 1757
2018
Q2
$5K Buy
99
+38
+62% +$1.92K ﹤0.01% 1579
2018
Q1
$2K Sell
61
-43
-41% -$1.41K ﹤0.01% 1887
2017
Q4
$3K Hold
104
﹤0.01% 1685
2017
Q3
$3K Buy
104
+43
+70% +$1.24K ﹤0.01% 1685
2017
Q2
$0 Hold
61
﹤0.01% 2051
2017
Q1
$1K Hold
61
﹤0.01% 1885
2016
Q4
$1K Buy
+61
New +$1K ﹤0.01% 1804
2016
Q1
Sell
-142
Closed -$1K 1974
2015
Q4
$1K Hold
142
﹤0.01% 1474
2015
Q3
$1K Hold
142
﹤0.01% 1114
2015
Q2
$1K Buy
+142
New +$1K ﹤0.01% 1091